Bio-tech firm Arcis-Altos raises £1m

A NORTH West company which has developed a product to kill the norovirus in just one minute, has raised £1m to fund further growth.

Arcis-Altos Group, based at Sci-Tech Daresbury, is behind the pioneering Noroclear disinfection product, has raised the new equity with Calculus Capital, one of the leading EIS (Entrepreneurs Investment Scheme) funds in the UK.

The funding will be used to accelerate R&D activities focusing on DNA extraction from cells and the subsequent protection of the DNA to allow diagnostic devices to provide a more accurate analysis.

This is expected to further revolutionise the molecular diagnostic sector, an area which is increasingly relied on in both medical and forensic sciences.

Peter Whitehurst, CEO at Arcis-Altos, said: “This is very welcome news at a key time for Arcis-Altos. We are delighted that Calculus Capital continues to strongly back Arcis-Altos and its management team.”

The business was created last year when Cheshire-based Arcis acquired California company Altos in a £3.7m deal.